Acurx Pharmaceuticals Files 8-K with Key Updates
Ticker: ACXP · Form: 8-K · Filed: Jul 31, 2025 · CIK: 1736243
Sentiment: neutral
Topics: corporate-action, filing-update
Related Tickers: ACRX
TL;DR
ACRX filed an 8-K on 7/31/25 - expect corporate changes and filings.
AI Summary
Acurx Pharmaceuticals, Inc. filed an 8-K on July 31, 2025, reporting material modifications to security holder rights and other events. The filing also includes amendments to its articles of incorporation or bylaws and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located in Staten Island, NY.
Why It Matters
This 8-K filing indicates significant corporate actions and potential changes affecting Acurx Pharmaceuticals' security holders and operational structure.
Risk Assessment
Risk Level: medium — 8-K filings can signal significant corporate events, but the specific impact requires further analysis of the detailed contents.
Key Players & Entities
- Acurx Pharmaceuticals, Inc. (company) — Registrant
- July 31, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 259 Liberty Avenue, Staten Island, NY 10305 (address) — Principal executive offices
FAQ
What specific material modifications were made to the rights of security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the provided text excerpt.
What are the key items reported in this 8-K filing?
This 8-K filing reports on Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on July 31, 2025.
Where are Acurx Pharmaceuticals, Inc.'s principal executive offices located?
Acurx Pharmaceuticals, Inc.'s principal executive offices are located at 259 Liberty Avenue, Staten Island, NY 10305.
What is the Standard Industrial Classification code for Acurx Pharmaceuticals, Inc.?
The Standard Industrial Classification code for Acurx Pharmaceuticals, Inc. is PHARMACEUTICAL PREPARATIONS [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding Acurx Pharmaceuticals, Inc. (ACXP).